Denmark Press Releases

Published on May 7, 2025 - 00:00 GMT

Arla Foods Ingredients menampilkan konsep soda protein di Vitafoods Europe

AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) -- Arla Foods Ingredients akan menyoroti manfaat fungsional dari pure BLG (beta-laktoglobulin) dalam konsep soda protein baru di Vitafoods Europe. Konsep soda protein Arla Foods Ingredients Konsumen semakin …

Distribution channels: Culture, Society & Lifestyle, Food & Beverage Industry ...

Published on May 7, 2025 - 00:00 GMT

Europe Arla Foods Ingredients นำเสนอแนวคิดโซดาโปรตีน ที่งาน Vitafoods Europe

AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) -- Arla Foods Ingredients จะเน้นคุณประโยชน์เชิงฟังก์ชันของ pure BLG (เบต้า-แลคโตโกลบูลิน) ในแนวคิดโซดาโปรตีนใหม่ที่งาน Vitafoods Europe แนวคิดโซดาโปรตีน Arla Foods Ingredients …

Distribution channels: Culture, Society & Lifestyle, Food & Beverage Industry ...

Published on May 7, 2025 - 00:00 GMT

Arla Foods Ingredients mempersembahkan konsep soda protein di Vitafoods Europe

AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) -- Arla Foods Ingredients akan menonjolkan manfaat fungsional pure BLG (beta-laktoglobulin) dalam konsep soda protein baru di Vitafoods Europe. Konsep Soda Protein Arla Foods Ingredients Pengguna kini semakin …

Distribution channels: Culture, Society & Lifestyle, Food & Beverage Industry ...

Published on May 7, 2025 - 00:00 GMT

Arla Foods Ingredients giới thiệu ý tưởng soda protein tại Vitafoods Europe

AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) -- Arla Foods Ingredients sẽ làm nổi bật lợi ích chức năng của pure BLG (beta-lactoglobulin) trong ý tưởng soda protein mới tại Vitafoods Europe. Ý tưởng soda protein của Arla Foods Ingredients Người tiêu dùng …

Distribution channels: Culture, Society & Lifestyle, Food & Beverage Industry ...

Published on May 6, 2025 - 05:30 GMT

DELÅRSRAPPORT 1. KVARTAL 2025 - 2025-TRANSITION GÅR FREMAD

Selskabsmeddelelse nr. 19 - 6. maj 2025 1. kvartal 2025 Omsætningen steg 8% til DKK 7,5 mia. Den organiske vækst var -1% EBIT reduceret DKK 317 mio. til DKK -117 mio. Justeret frit cash flow steg DKK 573 mio. til DKK 246 mio. CO2-færgeemissions-intensitet …

Distribution channels: Business & Economy, Shipping, Storage & Logistics ...

Published on May 6, 2025 - 05:30 GMT

Q1 2025 INTERIM REPORT - 2025-TRANSITION PROGRESSING

Announcement no. 19 - 6 May 2025 Q1 2025 Revenue up 8% to DKK 7.5bn. Organic growth was -1% EBIT reduced DKK 317m to DKK -117m Adjusted free cash flow increased DKK 573m to DKK 246m CO2 ferry emission intensity from own fleet lowered 5.9% Outlook 2025, …

Distribution channels: Business & Economy, Shipping, Storage & Logistics ...

Published on May 5, 2025 - 10:00 GMT

AgileOne Recognized as Top Global MSP Provider by HRO Today

AgileOne is honored to share that the company has been selected as the top global Managed Service Provider (MSP) by HRO Today. TORRANCE, CA, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- AgileOne is honored to share that the company has been …

Distribution channels: Automotive Industry, Aviation & Aerospace Industry ...

Published on May 5, 2025 - 10:11 GMT

ISS renews and expands public healthcare agreement in Southeast Asia

Copenhagen , May 05, 2025 (GLOBE NEWSWIRE) -- Under the agreement, ISS will deliver services across a range of healthcare institutions. It has a five-year duration, with an option to extend. Carl-Fredrik Bjor, Group Chief Commercial & Revenue Officer …

Distribution channels:

Published on May 2, 2025 - 17:00 GMT

EIN Presswire’s Debut Edition of ‘Heard on the Streets': PR Expert Clears Up Important PR Misconception

Sherrie Handrinos discusses how to earn media coverage and the key differences between earned PR and paid placement WASHINGTON, DC, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- In the debut edition of “Heard on the Streets,” a new series on …

Distribution channels: Agriculture, Farming & Forestry Industry, Amusement, Gaming & Casino ...

Published on May 2, 2025 - 00:14 GMT

Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus ...

Company Announcement Decision to submit based on a positive overall response rate (ORR) (p-value < 0.0001), one of the dual primary endpoints in the Phase 3 EPCORE® FL-1 trial Full results from the trial will be submitted for presentation at an upcoming …

Distribution channels: Technology ...

Published on May 1, 2025 - 17:09 GMT

ISS wins new business with Australian airport operator

Copenhagen , May 01, 2025 (GLOBE NEWSWIRE) -- ISS, a leading workplace experience and facility management company, has strengthened its partnership with key customer Australia Pacific Airports (Melbourne) through a new contract valued at approximately DKK …

Distribution channels: Business & Economy ...

Published on May 1, 2025 - 15:05 GMT

Zealand Pharma conference call on May 8 at 2pm CET (8am ET) to present first quarter 2025 financial results

Press Release – No. 7 / 2025 Zealand Pharma conference call on May 8 at 2pm CET (8am ET) to present first quarter 2025 financial results Copenhagen, Denmark, May 1, 2025 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a …

Distribution channels:

Published on April 30, 2025 - 20:26 GMT

3Huse Nordsjælland Sætter Nye Standarder for Moderne Bæredygtige Helårs Træhuse

3Huse Nordsjælland revolutionerer boligmarkedet med innovative, bæredygtige helårs træhuse, der kombinerer moderne design og energi-effektivitet. HELSINGøR, NORDSJæLLAND, DENMARK, May 1, 2025 /⁨EINPresswire.com⁩/ -- I en tid hvor bæredygtighed og …

Distribution channels: Building & Construction Industry, Furniture & Woodworking Industry ...

Published on April 29, 2025 - 14:00 GMT

WindESCo’s Swarm™ Wake Steering Validated by DNV: Delivers a 2.2% AEP Increase, Outperforming Industry Benchmarks

BURLINGTON, MA, UNITED STATES, April 29, 2025 /⁨EINPresswire.com⁩/ -- WindESCo, a global innovator in wind energy optimization, has announced the successful completion of a third-party validated measurement campaign of its Swarm™ wake steering solution at …

Distribution channels: Energy Industry ...

Published on April 29, 2025 - 13:19 GMT

cBrain aims to create and lead two new global solution niches

Company Announcement no. 05/2025 cBrain aims to create and lead two new global solution niches Copenhagen, April 29, 2025 The faster-than-anticipated shift in the government IT market toward COTS government software presents new strategic opportunities …

Distribution channels: IT Industry, Media, Advertising & PR ...

Published on April 28, 2025 - 07:11 GMT

UAE Positioned to Lead Global Longevity Movement as Nordic Laboratories Conference Takes Place in Dubai

As global focus turns to healthspan optimisation, a new wave of UAE-based practitioners is transforming how we age - inside and out. DUBAI, UNITED ARAB EMIRATES, April 28, 2025 /⁨EINPresswire.com⁩/ -- The UAE is rapidly establishing itself as a powerhouse …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...

Published on April 28, 2025 - 12:00 GMT

80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR ...

80% of EVX-01 vaccine targets triggered a tumor-specific immune response, a substantially higher frequency than what has been reported for other similar vaccine candidates The data underscores the precision of Evaxion’s AI-Immunology™ platform in selecting …

Distribution channels: Media, Advertising & PR, Technology ...

Published on April 28, 2025 - 08:00 GMT

Copenhagen Infrastructure Partners to partially divest Coalburn 1

COPENHAGEN, Denmark, April 28, 2025 (GLOBE NEWSWIRE) -- Copenhagen Infrastructure Partners (CIP), on behalf of its fund Copenhagen Infrastructure IV (CI IV), has signed an agreement to divest a 50% ownership stake, upon site commissioning, to AXA IM Alts, …

Distribution channels:

Published on April 25, 2025 - 12:00 GMT

Allarity Therapeutics Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025

TARPON SPRINGS, Fla., April 25, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—as a …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on April 24, 2025 - 05:00 GMT

Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or ...

Press release – No. 6 / 2025 Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes The Phase 2b ZUPREME-2 trial investigates the efficacy and safety of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Denmark Press Releases Distributed by EIN Presswire